3-stocks-under-$1:-buy-or-sell?

3 Stocks Under $1: BUY or SELL?

Amid fears of an economic slowdown ballooning, market volatilities are anticipated to linger for a while. Given such uncertainties, would it be wise to buy or avoid Advent Technologies Holdings (ADN), AEye, Inc. (LIDR), and Kidpik (PIK), trading under $1? Read on to find out…. The Fed’s incessant rate hikes to tame the sky-high inflation…

3-healthcare-stocks-all-insiders-are-buying,-should-you?

3 Healthcare Stocks ALL Insiders Are Buying, Should YOU?

Insider buying is often a good indicator of a company’s prospects, as insiders have information about the company that is unknown to the public and other retail investors. Although healthcare stocks Centene (CNC), Precigen (PGEN), and Beyond Air (XAIR) have insider buying, not all have strong fundamentals to hold out against market volatility. Keep reading.…

this-master-class-stock-has-investors-scrambling-to-buy

This Master Class Stock Has Investors Scrambling to Buy

The rising adoption of digital transactions is anticipated to keep the consumer financial services industry buoyed in the foreseeable future. Therefore, quality stock Mastercard Incorporated (MA) could be a wise portfolio addition now. Read on…. Financial inclusion has triggered a large increase in digital payments amid the global expansion of formal financial services. Global cashless…

3-of-the-worst-stocks-on-wall-street-right-now

3 of the Worst Stocks on Wall Street Right Now

The growing concerns about a potential recession, ongoing debt ceiling standoff, and predictions of prolonged high-interest rates might weigh on the US economy and stock market. Hence, it might be best to avoid fundamentally weak stocks CRISPR Therapeutics (CRSP), First Majestic Silver (AG), and McEwen Mining (MUX). Keep reading. Investors’ sentiments plunged amid bank failures…